Value Pharmapain Reliever
Product Images NDC 42787-102

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Value Pharmapain Reliever (NDC 42787-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajes Pharmaceuticals,llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Copy Of Label (Aspirin 325)

Copy Of Label (Aspirin 325)
This is a drug facts label containing information about regular strength aspirin tablets with 325mg of NSAID. The tablets are used to temporarily relieve headache pain, fever, muscle pain, menstrual pain, toothache pain, and minor pain from arthritis. The label warns not to use this product if you are allergic to pain relievers or fever reducers, and children or teenagers who have or are recovering from chickenpox should not use it. The product also carries several warnings, including that aspirin may cause severe allergic reactions, stomach bleeding, and Reyes syndrome, a rare but serious illness. Customers should ask a doctor first if stomach bleeding warning applies to them. The label recommends drinking a full glass of water with each dose, and not taking more than 12 tablets in 24 hours. People who are taking other NSAID-containing drugs, blood thinning or steroid drugs, prescription drugs for diabetes, gout, or arthritis, or those experiencing stomach problems should talk to their doctor before taking this medication. The label also offers other information regarding inactive ingredients, how to store this product, and what to do in case of an overdose.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.